Complement activation in acute coronary syndromes
Kenan Iltumur1, Aziz Karabulut, Gülten Toprak
1Department of Cardiology, Faculty of Medicine, Dicle University, 21280 Diyarbakýr, Turkey. kencan@cicle.edu.tr
Insights
Complement activation, measured by C3 and C4 levels, is elevated in patients with acute coronary syndromes (ACS) and stable angina (SA). These complement levels correlate with myocardial injury markers, suggesting a role in ischemic heart disease pathophysiology.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Background:
- The complement system, a key component of innate immunity, is increasingly implicated in cardiovascular disease.
- Understanding complement's role in ischemic heart disease is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate complement activation in patients with acute coronary syndromes (ACS).
- To correlate complement activation levels with markers of myocardial injury.
- To differentiate complement activation patterns across various ACS subtypes and stable angina.
Main Methods:
- Assessed plasma levels of Complement 3 (C3), Complement 4 (C4), C-reactive protein (CRP), troponin I (TnI), and creatine kinase MB (CK-MB) in 152 subjects.
- Included patients with acute myocardial infarction (AMI), non-Q wave MI (NQMI), unstable angina (UAP), stable angina (SA), and healthy controls.
- Collected blood samples at multiple time points for ACS patients and single measurements for stable angina and control groups.
Main Results:
- Significantly elevated C3 and C4 levels were observed in patients with AMI and NQMI compared to SA and controls.
- Patients with SA and UAP also showed higher C3 and C4 levels than controls.
- Complement levels (C3, C4) correlated positively with myocardial injury markers (CK-MB, TnI) and CRP in ACS patients.
Conclusions:
- Plasma C3 and C4 levels are elevated in ACS and SA, indicating complement activation in ischemic heart disease.
- The degree of complement activation correlates with the extent of myocardial necrosis.
- Complement activation is a significant factor in the pathophysiology of acute coronary syndromes.
Abstract:
The complement system is part of the host defence response. However, considerable evidence suggests that complement plays an important role in the pathophysiology of ischemic heart disease. The aim of this study was to evaluate complement activation in patients with all forms of acute coronary syndromes (ACS) and to examine the relationship between the degree of complement activation and myocardial injury. The study population included 152 subjects (26 females): 82 with ACS (35 acute myocardial infarction (AMI), 22 non-Q wave MI (NQMI), 25 unstable angina (UAP)) (Group A), 35 stable angina (SA) (Group B), and 35 healty control subjects (Group C). Complement 3 (C3), Complement 4 (C4), C-reactive protein (CRP), troponin I (TnI) as well as creatine kinase MB (CK-MB) were evaluated. Patients' blood samples were taken on admission (day 1) and after 2, 3 and 7 days in group A. However, only one measurement was performed in the groups B and C. Plasma C3 and C4 peak levels were significantly higher in patients with AMI (141+/-29 and 35+/-11 mg/dl) and NQMI (136+/-13 and 35+/-7 mg/dl) than in patients with SA (128+/-14 and 27+/-10 mg/dl) and the control subjects (114+/-22 and 22+/-7 mg/dl) (p<0.03). Also, C3 and C4 serum levels in patients with SA and UAP (126+/-16 and 31+/-7 mg/dl) were significantly higher than those in control subjects (p<0.01, p<0.03, respectively). At 1-week follow-up, there were no significant differences between the plasma levels of C3 and C4 in patients with UAP (p>0.05). However, plasma levels of C3 and C4 were significantly different between days in patients with AMI and NQMI (p<0.0001). Plasma C3 and C4 levels in ACS showed a relationship with peak CK-MB and Tn I levels (p<0.01). Plasma CRP level in ACS showed positive correlation with C3 (p<0.01) and C4 (p<0.001). In this study, we determined that plasma C3 and C4 levels were elevated in ACS and SA. Although C3 and C4 were higher in ACS and SA, the systemic levels of inflammatory markers in patients with SA and UAP were lower than those found in the AMI and NQMI groups. The relationship between C3, C4 levels and ACS further suggests that the complement activation is related to necrosis within the myocardium.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Complement System
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management

